Everson GT - Search Results

1

Advances in noninvasive measurement of liver function and physiology: The HepQuant DuO test.

McRae MP, Kittelson J, Helmke SM, Everson GT. McRae MP, et al. Among authors: everson gt. Basic Clin Pharmacol Toxicol. 2024 Mar;134(3):385-395. doi: 10.1111/bcpt.13980. Epub 2024 Jan 15. Basic Clin Pharmacol Toxicol. 2024. PMID: 38225212

2

Advances in management of polycystic liver disease.

Everson GT, Helmke SM, Doctor B. Everson GT, et al. Expert Rev Gastroenterol Hepatol. 2008 Aug;2(4):563-76. doi: 10.1586/17474124.2.4.563. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072404 Review.

3

Somatostatin, estrogen, and polycystic liver disease.

Everson GT, Helmke SM. Everson GT, et al. Gastroenterology. 2013 Aug;145(2):279-82. doi: 10.1053/j.gastro.2013.06.025. Epub 2013 Jun 24. Gastroenterology. 2013. PMID: 23806538 No abstract available.

4

Noninvasive assessment of liver function.

Helmke S, Colmenero J, Everson GT. Helmke S, et al. Among authors: everson gt. Curr Opin Gastroenterol. 2015 May;31(3):199-208. doi: 10.1097/MOG.0000000000000167. Curr Opin Gastroenterol. 2015. PMID: 25714706 Free PMC article. Review.

5

Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.

Lemmer A, VanWagner L, Gasanova Z, Helmke S, Everson GT, Ganger D. Lemmer A, et al. Among authors: everson gt. Congenit Heart Dis. 2019 Nov;14(6):978-986. doi: 10.1111/chd.12831. Epub 2019 Aug 1. Congenit Heart Dis. 2019. PMID: 31369200 Free PMC article.

6

The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology.

Burton JR Jr, Helmke S, Lauriski S, Kittelson J, Everson GT. Burton JR Jr, et al. Among authors: everson gt. Transl Res. 2021 Jul;233:5-15. doi: 10.1016/j.trsl.2020.12.010. Epub 2021 Jan 2. Transl Res. 2021. PMID: 33400995 Clinical Trial.

7

Predicting clinical decompensation in patients with cirrhosis using the Hepquant-SHUNT test.

Fallahzadeh MA, Hansen DJ, Trotter JF, Everson GT, Saracino G, Rahimi RS, Helmke S, Boutte J, Asrani SK. Fallahzadeh MA, et al. Among authors: everson gt. Aliment Pharmacol Ther. 2021 Apr;53(8):928-938. doi: 10.1111/apt.16283. Epub 2021 Feb 8. Aliment Pharmacol Ther. 2021. PMID: 33556192

8

HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease.

Wieland A, Etzion O, Ali RO, Levy E, Kleiner DE, Helmke SM, Heller T, Everson GT. Wieland A, et al. Among authors: everson gt. Clin Gastroenterol Hepatol. 2022 Apr;20(4):e890-e894. doi: 10.1016/j.cgh.2021.04.030. Epub 2021 Apr 22. Clin Gastroenterol Hepatol. 2022. PMID: 33895359 Free PMC article.

9

Compartmental model describing the physiological basis for the HepQuant SHUNT test.

McRae MP, Helmke SM, Burton JR Jr, Everson GT. McRae MP, et al. Among authors: everson gt. Transl Res. 2023 Feb;252:53-63. doi: 10.1016/j.trsl.2022.08.002. Epub 2022 Aug 7. Transl Res. 2023. PMID: 35948199

10

Within-individual reproducibility of a dual sample oral cholate challenge test (DuO) and simplified versions of the HepQuant SHUNT test.

McRae MP, Kittelson J, Helmke SM, Everson GT. McRae MP, et al. Among authors: everson gt. Clin Transl Sci. 2024 Apr;17(4):e13786. doi: 10.1111/cts.13786. Clin Transl Sci. 2024. PMID: 38558534 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page